These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 19526281)
1. Mutant alpha-synuclein overexpression mediates early proinflammatory activity. Su X; Federoff HJ; Maguire-Zeiss KA Neurotox Res; 2009 Oct; 16(3):238-54. PubMed ID: 19526281 [TBL] [Abstract][Full Text] [Related]
2. α-Synuclein fibrils recruit peripheral immune cells in the rat brain prior to neurodegeneration. Harms AS; Delic V; Thome AD; Bryant N; Liu Z; Chandra S; Jurkuvenaite A; West AB Acta Neuropathol Commun; 2017 Nov; 5(1):85. PubMed ID: 29162163 [TBL] [Abstract][Full Text] [Related]
3. Microglia-inhibiting activity of Parkinson's disease drug amantadine. Kim JH; Lee HW; Hwang J; Kim J; Lee MJ; Han HS; Lee WH; Suk K Neurobiol Aging; 2012 Sep; 33(9):2145-59. PubMed ID: 22035588 [TBL] [Abstract][Full Text] [Related]
4. Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson's disease. Rojo AI; Innamorato NG; Martín-Moreno AM; De Ceballos ML; Yamamoto M; Cuadrado A Glia; 2010 Apr; 58(5):588-98. PubMed ID: 19908287 [TBL] [Abstract][Full Text] [Related]
5. Evidence for a role of adaptive immune response in the disease pathogenesis of the MPTP mouse model of Parkinson's disease. Martin HL; Santoro M; Mustafa S; Riedel G; Forrester JV; Teismann P Glia; 2016 Mar; 64(3):386-95. PubMed ID: 26511587 [TBL] [Abstract][Full Text] [Related]
6. Brain-resident microglia predominate over infiltrating myeloid cells in activation, phagocytosis and interaction with T-lymphocytes in the MPTP mouse model of Parkinson disease. Depboylu C; Stricker S; Ghobril JP; Oertel WH; Priller J; Höglinger GU Exp Neurol; 2012 Dec; 238(2):183-91. PubMed ID: 22964486 [TBL] [Abstract][Full Text] [Related]
7. Analysis of monocyte infiltration in MPTP mice reveals that microglial CX3CR1 protects against neurotoxic over-induction of monocyte-attracting CCL2 by astrocytes. Parillaud VR; Lornet G; Monnet Y; Privat AL; Haddad AT; Brochard V; Bekaert A; de Chanville CB; Hirsch EC; Combadière C; Hunot S; Lobsiger CS J Neuroinflammation; 2017 Mar; 14(1):60. PubMed ID: 28320442 [TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effect of ghrelin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease by blocking microglial activation. Moon M; Kim HG; Hwang L; Seo JH; Kim S; Hwang S; Kim S; Lee D; Chung H; Oh MS; Lee KT; Park S Neurotox Res; 2009 May; 15(4):332-47. PubMed ID: 19384567 [TBL] [Abstract][Full Text] [Related]
9. GPR34 in spinal microglia exacerbates neuropathic pain in mice. Sayo A; Konishi H; Kobayashi M; Kano K; Kobayashi H; Hibi H; Aoki J; Kiyama H J Neuroinflammation; 2019 Apr; 16(1):82. PubMed ID: 30975169 [TBL] [Abstract][Full Text] [Related]
10. Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-γ agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson's disease. Pisanu A; Lecca D; Mulas G; Wardas J; Simbula G; Spiga S; Carta AR Neurobiol Dis; 2014 Nov; 71():280-91. PubMed ID: 25134730 [TBL] [Abstract][Full Text] [Related]
11. Synuclein activates microglia in a model of Parkinson's disease. Su X; Maguire-Zeiss KA; Giuliano R; Prifti L; Venkatesh K; Federoff HJ Neurobiol Aging; 2008 Nov; 29(11):1690-701. PubMed ID: 17537546 [TBL] [Abstract][Full Text] [Related]
12. The role of Galectin-3 in α-synuclein-induced microglial activation. Boza-Serrano A; Reyes JF; Rey NL; Leffler H; Bousset L; Nilsson U; Brundin P; Venero JL; Burguillos MA; Deierborg T Acta Neuropathol Commun; 2014 Nov; 2():156. PubMed ID: 25387690 [TBL] [Abstract][Full Text] [Related]
13. A spirulina-enhanced diet provides neuroprotection in an α-synuclein model of Parkinson's disease. Pabon MM; Jernberg JN; Morganti J; Contreras J; Hudson CE; Klein RL; Bickford PC PLoS One; 2012; 7(9):e45256. PubMed ID: 23028885 [TBL] [Abstract][Full Text] [Related]
14. α-Synuclein disrupts the anti-inflammatory role of Drd2 via interfering β-arrestin2-TAB1 interaction in astrocytes. Du RH; Zhou Y; Xia ML; Lu M; Ding JH; Hu G J Neuroinflammation; 2018 Sep; 15(1):258. PubMed ID: 30200997 [TBL] [Abstract][Full Text] [Related]
15. Cyclic AMP is a key regulator of M1 to M2a phenotypic conversion of microglia in the presence of Th2 cytokines. Ghosh M; Xu Y; Pearse DD J Neuroinflammation; 2016 Jan; 13():9. PubMed ID: 26757726 [TBL] [Abstract][Full Text] [Related]
16. Astrocyte-microglia cooperation in the expression of a pro-inflammatory phenotype. Barbierato M; Facci L; Argentini C; Marinelli C; Skaper SD; Giusti P CNS Neurol Disord Drug Targets; 2013 Aug; 12(5):608-18. PubMed ID: 23574172 [TBL] [Abstract][Full Text] [Related]
17. Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson's disease. Williams GP; Schonhoff AM; Jurkuvenaite A; Thome AD; Standaert DG; Harms AS J Neuroinflammation; 2018 Aug; 15(1):244. PubMed ID: 30165873 [TBL] [Abstract][Full Text] [Related]
19. Microglial activation and antioxidant responses induced by the Parkinson's disease protein α-synuclein. Béraud D; Hathaway HA; Trecki J; Chasovskikh S; Johnson DA; Johnson JA; Federoff HJ; Shimoji M; Mhyre TR; Maguire-Zeiss KA J Neuroimmune Pharmacol; 2013 Mar; 8(1):94-117. PubMed ID: 23054368 [TBL] [Abstract][Full Text] [Related]
20. Identification of a specific α-synuclein peptide (α-Syn 29-40) capable of eliciting microglial superoxide production to damage dopaminergic neurons. Wang S; Chu CH; Guo M; Jiang L; Nie H; Zhang W; Wilson B; Yang L; Stewart T; Hong JS; Zhang J J Neuroinflammation; 2016 Jun; 13(1):158. PubMed ID: 27329107 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]